Detalhe da pesquisa
1.
Long-term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety.
Am J Gastroenterol
; 2023 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561058
2.
Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase.
Hepatology
; 73(5): 1652-1670, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32780526
3.
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts.
Liver Int
; 42(6): 1386-1400, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35025128
4.
New therapies for hepatitis delta virus infection.
Liver Int
; 41 Suppl 1: 30-37, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34155804
5.
Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real-life.
Liver Int
; 41(7): 1509-1517, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33999515
6.
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Lancet
; 393(10179): 1453-1464, 2019 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765123
7.
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Gastroenterology
; 156(4): 997-1009.e5, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768988
8.
Sofosbuvir-Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real-life experience from the HEPATHER ANRS CO22 cohort.
J Viral Hepat
; 27(10): 964-973, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436335
9.
Future treatments for hepatitis delta virus infection.
Liver Int
; 40 Suppl 1: 54-60, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32077603
10.
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
Gastroenterology
; 155(5): 1436-1450.e6, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30031138
11.
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Gastroenterology
; 155(2): 431-442.e10, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29729258
12.
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort.
J Viral Hepat
; 26(3): 384-396, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30380181
13.
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication.
Hepatology
; 68(4): 1245-1259, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29663511
14.
Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection.
Liver Int
; 39(10): 1868-1875, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31136052
15.
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort.
BMC Infect Dis
; 19(1): 300, 2019 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30940090
16.
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
Dig Dis Sci
; 64(1): 285-286, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30324553
17.
96â¯weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection.
J Hepatol
; 68(4): 672-681, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29756595
18.
No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection.
Antimicrob Agents Chemother
; 62(10)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30038044
19.
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
Gastroenterology
; 152(1): 142-156.e2, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27641509
20.
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients.
Am Heart J
; 198: 4-17, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653647